好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2004 Annual Meeting | Aging and Dementia: Clinical

Wednesday 04/28/04
02:15 PM - 03:45 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Platform Session
Aging and Dementia
No CME available
Event Timeline
02:15 PM - 03:45 PM Abstract 001 - Diabetes Mellitus and Progression of Rigidity and Gait Disturbance in Older Persons
02:15 PM - 03:45 PM Abstract 002 - Type 2 Diabetes and Cognitive Decline: A Prospective Study
02:15 PM - 03:45 PM Abstract 003 - High Signal Intensity Volume Predicts the Time to Dementia among Normal Aging and Early Cognitive Impairment
02:15 PM - 03:45 PM Abstract 004 - The Relationship of Sex Steroid Hormones to Brain Morphology and Cognition in Elderly Males
02:15 PM - 03:45 PM Abstract 005 - Prevalence of Dementia Etiologies in Minorities
02:15 PM - 03:45 PM Abstract 006 - Stability of Cerebrospinal Fluid Markers of Alzheimer's Disease over 3 Months
Faculty Disclosures
Bradley F. Boeve, MD, FAAN Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Douglas Galasko, MD Dr. Galasko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Galasko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for vTv Therapeutics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fujirebio. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BioMed Central.
No disclosure on file
Nader N. Antonios, MD No disclosure on file
Maryna Skliut, MD Dr. Skliut has nothing to disclose.
Zhimin Xu, MD, PhD Dr. Xu has nothing to disclose.
Fahed Saada, MD, FAAN No disclosure on file
Pierre-Marie Preux, MD No disclosure on file
Marcelo E. Cruz, MD No disclosure on file
Antonio Cruz, MD No disclosure on file